HOME >> MEDICINE >> NEWS
Long-term data on safety and effectiveness of antiobesity drugs needed

Data on the long-term effects of antiobesity drugs is needed so doctors can be confident that their benefits outweigh their risks, state the authors of a New Drug Class article in this week's issue of The Lancet.

The International Obesity Task Force estimates that more than 300 million individuals worldwide are obese and an additional 800 million are overweight. Antiobesity treatment is recommended for selected patients if lifestyle modification has been unsuccessful. Currently, two antiobesity drugs orlistat and sibutramine - are licensed for long term use. Raj Padwal and Sumit Majumdar from the University of Alberta Hospital, Edmonton, AB, Canada assess these drugs as well as rimonabant the first of a new class of antiobesity drug known as the endocannabinoid receptor antagonists. They conclude that trials on the drugs have been limited by lack of long-term data on major obesity-related illness and death, particularly cardiovascular outcomes.

The authors conclude: "In light of the lack of successful weight-loss treatments and the public-health implications of the obesity pandemic, the development of safe and effective drugs should be a priorityWe think that antiobesity drug trials powered to show clinically important reductions in major obesity-related morbidity and mortality should be required either before these drugs are approved for widespread use or as a condition of ongoing approval."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
4-Jan-2007


Page: 1

Related medicine news :

1. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
2. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
3. Long-term aspirin use associated with reduced risk of dying in women
4. Long-term financial costs associated with prostate cancer treatment
5. Long-term effects of non-alcoholic fatty liver disease
6. Long-term outcomes for prostate cancer show IMRT Curative: 89 percent disease-free 8 years later
7. Long-term abstinence may resolve many of the neurocognitive deficits associated with alcoholism
8. Long-term safety results released for breast cancer drugs
9. Long-term ibuprofen regimen after brain injury worsens cognition in animal study
10. Media availability: Long-term survival of heart attack patients with shock
11. Long-term estrogen therapy linked to breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Ocean ... face masks to medical first responders across the United States. Since the start ... personal protective equipment (PPE) medical centers , hospitals , firefighters ...
(Date:8/31/2020)... ... 2020 , ... Smile Brands Inc., one of the nation’s ... today announced the grand opening of another affiliated Bright Now! Dental office ... hours, a comfortable office, and full-service care at the new Beaumont location. The ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang has ... with autism and other developmental disabilities, as well as supporting staff in caring ... with autism, school consultation, and staff development. She joined the company in 2015 ...
(Date:8/28/2020)... TUCSON, Ariz. (PRWEB) , ... August 28, 2020 ... ... helium-oxygen respiratory assist system designed to help treat patients with respiratory conditions, including ... a mixture of helium and oxygen, but it captures exhaled gas and scrubs ...
(Date:8/28/2020)... CHICAGO (PRWEB) , ... August 28, 2020 , ... ... its role in advising Adventist Health on its investment in Synchronous Health, a ... health company that combines the strength of human empathy with artificial intelligence (AI) ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... CLARA, Calif. (PRWEB) , ... September 01, 2020 ... ... and analytical laboratory technologies, will host the Agilent Science and Technology Virtual ... During this two-day symposium, Agilent will open a suite of Live webinars and ...
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are common diseases ... 3% of breast cancers (about 7,500 women per year) and 10% of ovarian cancers ... genes. Both genes are detectable in the Women’s Excellence Genetic Testing Program. , ...
(Date:8/31/2020)... ... August 31, 2020 , ... Continuing on its rapid ... sanitization, disinfection and deodorization provider - is proud to announce it has opened ... for businesses and residents throughout the area. , Germinator provides a 100% safe ...
Breaking Medicine Technology:
Cached News: